Remove 2024 Remove ACE Inhibitor Remove Hypertension
article thumbnail

Abstract TMP97: Temporal Trends in Black-White Differences of Antihypertensive Treatment in Individuals With and Without History of Stroke: Reasons for Geographic and Racial Differences in Stroke (REGARDS)

Stroke Journal

Stroke, Volume 55, Issue Suppl_1 , Page ATMP97-ATMP97, February 1, 2024. Conclusions:Consistent with JNC8 recommendations for first-line medication administration in Black persons with hypertension, there was a higher likelihood of CCB use over time among Black participants in REGARDS.

article thumbnail

Abstract 4142012: Ectasias of Multiple Coronary Arteries and a Coronary Cameral Fistula Between Right Coronary Artery and Coronary Sinus

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4142012-A4142012, November 12, 2024. Case Description:A 59-year-old male with history of hypertension, diabetes, Hashimoto’s thyroiditis presented with new, progressive shortness of breath. No murmur or extra heart sound were heard, and the lung sounds were normal.

article thumbnail

What Should Your Blood Pressure Be?

Dr. Paddy Barrett

Most people with high blood pressure will be treated with an ACE inhibitor, ARB, calcium channel blocker or a diuretic. 1 The global epidemiology of hypertension. Hypertension. Hypertension. 2024 Nov;81(11):2329-2339. What Medication To Get To Target? There are others also. Nat Rev Nephrol. N Engl J Med.

article thumbnail

FDA Accepts, Grants Priority Review Designation for Bayer's msNRA for Patients with Heart Failure

DAIC

2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). In fact, a 2024 report on heart failure trends and outcomes published in the Journal of Cardiac Failure showed that in patients with heart failure with preserved ejection fraction, 5-year mortality was 75.7%.

article thumbnail

Abstract 4134796: Safety of over 1000 consecutive, selected low risk patients with accelerated discharge from a chest pain unit with early generation cardiac troponin use, no cardiac functional or anatomic testing and no clinical risk scores

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4134796-A4134796, November 12, 2024. Women received more discharge cardiac medications than men: antiplatelet agents, statins, beta blockers, ACE inhibitors, angiotensin II blockers, calcium channel blockers, and nitrates (p=0.0002 - 0.04).Follow-up